COSM
Cosmos Health, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.33
+11.10%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.30
From 52W high−73.66%
Volume6.07M
Market cap$33.13M
P/E (TTM)—
P/S (TTM)0.4x
Div yield—
Key dataSep 18, 2026
Open
$0.30
From 52W high
−73.66%
Volume
6.07M
Market cap
$33.13M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.4x
P/E (TTM)
—
RSI (14)
73.4
MomentumView details →
1D Return
+11.10%
YTD Return
−34.30%
SummaryUpdated Jun 1, 2026
Cosmos Health Inc. (NASDAQ:COSM) is a vertically integrated pharmaceutical company founded in 2009 and headquartered in Chicago, Illinois. The company went public in July 2010 and operates as a specialty pharmaceutical manufacturer and distributor with a focus on branded and generic pharmaceuticals, nutraceuticals, and medical devices. Cosmos Health has established distribution operations across multiple countries, with key facilities in Greece and the United Kingdom, serving wholesale pharmaceutical distributors and independent retail pharmacies through both traditional distribution channels and e-commerce platforms.
Similar companies
Latest newsMore news →
Cosmos Health Inc. announced the launch of its Oliv18 nutraceutical product, a whole olive polyphenol formulation, with a staged rollout beginning with direct-to-consumer e-commerce and planned expansion into retail channels.27d agoCosmos Health Inc. reported Q2 2026 GAAP revenue of $18.99 million, up 28.8% year-over-year, with a net loss of $6.09 million and adjusted EBITDA of -$1.13 million.32d ago